1. María Gómez-Lázaro, PhD. 2. Graduated in Biochemistry, 2002 (University of Valencia, Spain); Master degree in Research, Development, and Innovation of Novel Drugs, 2003 (University of Pamplona, Spain); Master online in Neuroscience and Behavioral Biology (University Pablo de Olavide, Spain); PhD in Medical Sciences, 2007 (University of Castilla-La Mancha, Spain). 3. Post-doc at the Center of Cell Biology, University of Aveiro (2007-2010); Post-doc at the Institute for Research in Neurological Disabilities (IDINE) (2010–2012), University of Castilla-La Mancha; Platform head of the Bio-imaging Scientific Platform from i3S from 2012. 4. Research interest in neuroscience and different neurodegenerative diseases, with a focus on mitochondria and the extracellular matrix. 5. Award from the HEFAME foundation for the best PhD thesis of 2007 (Murcia, Spain); Molecular and cellular mechanisms involved in the modulation of mitochondrial membranes' permeability in different models of neurological diseases; Award from the Santa María de España Pharmacy Academy of Murcia, Murcia, Spain; Molecular and cellular mechanisms involved in the modulation of mitochondrial membranes' permeabilization in Parkinson's disease in 2007; Award for attendance at the Spanish Neuroscience Society Congress in 2005; Award for attendance at the XVII Congress of the Spanish Society of Medical Education in 2005.